全文获取类型
收费全文 | 3466篇 |
免费 | 165篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 33篇 |
儿科学 | 162篇 |
妇产科学 | 73篇 |
基础医学 | 401篇 |
口腔科学 | 144篇 |
临床医学 | 230篇 |
内科学 | 682篇 |
皮肤病学 | 106篇 |
神经病学 | 191篇 |
特种医学 | 125篇 |
外科学 | 405篇 |
综合类 | 133篇 |
一般理论 | 3篇 |
预防医学 | 297篇 |
眼科学 | 59篇 |
药学 | 334篇 |
中国医学 | 12篇 |
肿瘤学 | 263篇 |
出版年
2023年 | 22篇 |
2022年 | 49篇 |
2021年 | 129篇 |
2020年 | 61篇 |
2019年 | 75篇 |
2018年 | 116篇 |
2017年 | 86篇 |
2016年 | 103篇 |
2015年 | 92篇 |
2014年 | 127篇 |
2013年 | 154篇 |
2012年 | 245篇 |
2011年 | 242篇 |
2010年 | 133篇 |
2009年 | 109篇 |
2008年 | 210篇 |
2007年 | 187篇 |
2006年 | 172篇 |
2005年 | 177篇 |
2004年 | 143篇 |
2003年 | 100篇 |
2002年 | 119篇 |
2001年 | 65篇 |
2000年 | 69篇 |
1999年 | 56篇 |
1998年 | 24篇 |
1997年 | 14篇 |
1996年 | 19篇 |
1995年 | 23篇 |
1994年 | 19篇 |
1993年 | 12篇 |
1992年 | 32篇 |
1991年 | 22篇 |
1990年 | 32篇 |
1989年 | 31篇 |
1988年 | 34篇 |
1987年 | 24篇 |
1986年 | 22篇 |
1985年 | 21篇 |
1984年 | 20篇 |
1983年 | 17篇 |
1982年 | 11篇 |
1981年 | 16篇 |
1979年 | 22篇 |
1978年 | 13篇 |
1976年 | 15篇 |
1975年 | 10篇 |
1973年 | 11篇 |
1972年 | 10篇 |
1967年 | 9篇 |
排序方式: 共有3653条查询结果,搜索用时 109 毫秒
81.
Altered localization and activity of canalicular Mrp2 in estradiol-17beta-D-glucuronide-induced cholestasis 总被引:10,自引:0,他引:10
Mottino AD Cao J Veggi LM Crocenzi F Roma MG Vore M 《Hepatology (Baltimore, Md.)》2002,35(6):1409-1419
Estradiol-17beta-D-glucuronide (E(2)17G), an endogenous metabolite of estradiol, induces a potent dose-dependent and reversible inhibition of bile flow in the rat. We analyzed the effect of a single dose of E(2)17G (15 micromol/kg, intravenously) to female rats on bile flow and the endocytic retrieval and function of the canalicular multidrug resistance-associated protein 2 (Mrp2) and the effect of pretreatment with dibutyryl-cyclic AMP (DBcAMP; 20 micromol/kg) on these measures. Bile flow was maximally inhibited by 85% within 10 minutes of E(2)17G and returned to 50% and 100% of control levels within 75 and 120 minutes, respectively. Western analysis of total homogenates and mixed plasma and intracellular membranes suggested partial internalization of Mrp2 during the acute phase of cholestasis at 20 minutes and during the period of recovery from cholestasis at 75 minutes, which returned to control levels by 180 minutes after E(2)17G. Confocal analysis confirmed Western studies and demonstrated endocytic retrieval of Mrp2 from the canalicular membrane into pericanalicular and intracellular domains. The biliary concentration and excretion of the model Mrp2 substrate, dinitrophenyl-S-glutathione (DNP-SG), was impaired in parallel with the extent of Mrp2 retrieval. Pretreatment with DBcAMP partially protected against maximal E(2)17G cholestasis and the endocytic retrieval and decreased function of Mrp2 at 20 minutes and significantly accelerated the exocytic insertion of Mrp2 into the canalicular membrane and the recovery of bile flow and biliary excretion of DNP-SG. In conclusion, these data indicate that E(2)17G induces endocytic internalization of Mrp2, which occurs in parallel with decreased bile flow and Mrp2 transport activity. 相似文献
82.
Longitudinal variations of laryngeal overpressure and voice‐related quality of life in spasmodic dysphonia 下载免费PDF全文
83.
Eriko Kikuchi Takayasu Mori Moko Zeniya Kiyoshi Isobe Mari Ishigami-Yuasa Shinya Fujii Hiroyuki Kagechika Tomoaki Ishihara Tohru Mizushima Sei Sasaki Eisei Sohara Tatemitsu Rai Shinichi Uchida 《Journal of the American Society of Nephrology : JASN》2015,26(7):1525-1536
Upon activation by with-no-lysine kinases, STE20/SPS1-related proline–alanine-rich protein kinase (SPAK) phosphorylates and activates SLC12A transporters such as the Na+-Cl− cotransporter (NCC) and Na+-K+-2Cl− cotransporter type 1 (NKCC1) and type 2 (NKCC2); these transporters have important roles in regulating BP through NaCl reabsorption and vasoconstriction. SPAK knockout mice are viable and display hypotension with decreased activity (phosphorylation) of NCC and NKCC1 in the kidneys and aorta, respectively. Therefore, agents that inhibit SPAK activity could be a new class of antihypertensive drugs with dual actions (i.e., NaCl diuresis and vasodilation). In this study, we developed a new ELISA-based screening system to find novel SPAK inhibitors and screened >20,000 small-molecule compounds. Furthermore, we used a drug repositioning strategy to identify existing drugs that inhibit SPAK activity. As a result, we discovered one small-molecule compound (Stock 1S-14279) and an antiparasitic agent (Closantel) that inhibited SPAK-regulated phosphorylation and activation of NCC and NKCC1 in vitro and in mice. Notably, these compounds had structural similarity and inhibited SPAK in an ATP-insensitive manner. We propose that the two compounds found in this study may have great potential as novel antihypertensive drugs. 相似文献
84.
Urinary Kidney injury molecule‐1 can predict delayed graft function in living donor renal allograft recipients 下载免费PDF全文
85.
Vandana Rai 《Metabolic brain disease》2016,31(4):727-735
Autism (MIM 209850) is a heterogeneous neurodevelopmental disease that manifests within the first 3 years of life. Numerous articles reported that dysfunctional folate-methionine pathway enzymes may play an important role in the pathophysiology of autism. Methylenetetrahydrofolate reductase (MTHFR) is a critical enzyme of this pathway and MTHFR C677T polymorphism reported as risk factor for autism in several case control studies. However, controversial reports were also published. Hence the present meta-analysis was designed to investigate the relationship of the MTHFR C677T polymorphism with the risk of autism. Electronic databases were searched for case control studies with following search terms - ‘MTHFR’, ‘C677T’, in combination with ‘Autism’. Pooled OR with its corresponding 95 % CI was calculated and used as association measure to investigate the association between MTHFR C677T polymorphism and risk of autism. Total of thirteen studies were found suitable for the inclusion in the present meta-analysis, which comprises 1978 cases and 7257 controls. Meta-analysis using all four genetic models showed significant association between C677T polymorphism and autism (ORTvs.C = 1.48; 95 % CI: 1.18–1.86; P = 0.0007; ORTT + CT vs. CC = 1.70, 95 % CI = 0.96–2.9, p = 0.05; ORTT vs. CC = 1.84, 95 % CI = 1.12–3.02, p = 0.02; ORCT vs.CC = 1.60, 95 % CI = 1.2–2.1, p = 0.003; ORTT vs.CT+CC = 1.5, 95 % CI = 1.02–2.2, p = 0.03). In total 13 studies, 9 studies were from Caucasian population and 4 studies were from Asian population. The association between C677T polymorphism and autism was significant in Caucasian (ORTvs.C = 1.43; 95 % CI = 1.1–1.87; p = 0.009) and Asian population (ORTvs.C = 1.68; 95 % CI = 1.02–2.77; p = 0.04) using allele contrast model. In conclusion, present meta-analysis strongly suggested a significant association of the MTHFR C677T polymorphism with autism. 相似文献
86.
Miyata M Sakuma F Fukaya E Kobayashi H Rai T Saito H Kasukawa R Suzuki S 《Internal medicine (Tokyo, Japan)》2002,41(6):467-473
The applicability of monitoring concentrations of serum KL-6 and serum surfactant protein-D (SP-D) in the detection of methotrexate-associated lung injury (MTX pneumonitis) in patients with rheumatoid arthritis (RA) was investigated. The concentrations of these markers, sequentially measured in two patients with RA complicated with MTX pneumonitis, were increased in accordance with the severity of MTX pneumonitis. Conversely, the concentrations of these markers were decreased with the improvement of MTX pneumonitis, suggesting that the monitoring of these markers could be applicable not only for detecting the onset of MTX pneumonitis, but also for detecting the therapeutic response of MTX pneumonitis. 相似文献
87.
88.
89.
Sachin Rai Vidya Rattan Sanjay K. Bhadada 《Journal of maxillofacial and oral surgery》2015,14(4):930-934
Aims and Objective
To evaluate the prevalence, clinical features, diagnostic laboratory values and treatment outcome of giant cell lesions (brown tumors) associated with primary hyperparathyroidism (PHPT) in oral and maxillofacial region.Study Design
A 5 year retrospective data was analyzed wherein all histopathologically proven cases of giant cell lesions involving oral and maxillofacial region were evaluated. Out of these cases, those associated with PHPT were tabulated. Correlation was established with other concomitant clinical features and also with the laboratory values of altered serum calcium, phosphate, alkaline phosphate and parathormone. Follow up of these cases after the correction of PHPT was also noted.Result
Out of 85 cases of histopathologically proven giant cell lesions, five cases were associated with PHPT. There was involvement of maxilla and mandible in one case each. Only frontal bone was involved in two cases. Fifth case had multiple lytic lesions in maxilla and frontal bone. All patients consistently showed very high values of alkaline phosphate and parathormone. Hypercalcemia and hypophosphatemia was noted in four cases. All cases showed regression of the lytic lesion after parathyroidectomy obviating the need for surgical excision of the jaw lesions.Conclusion
Giant cell lesions (brown tumors) associated with PHPT in oral and maxillofacial region are rare clinical entities. The prevalence of PHPT associated giant cell lesions is 5.9 %. They are clinically, radiologically and histopathologically similar to any other peripheral or central giant cell tumor. Relevant history may alert the clinician and altered biochemical values may help in correlating the oral and maxillofacial findings with the underlying systemic disease. At times, the brown tumor maybe the only presenting sign leading to the diagnosis of PHPT. 相似文献90.